NCT03764826

Brief Summary

This study is to compare the effect of Cochleural Alternating Acoustic Beam Therapy(CAABT) and tinnitus masking therapy(TMT) on chronic primary tinnitus.Half of participants will receive CAABT, while the other half will receive TMT.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2018

Completed
1 day until next milestone

Study Start

First participant enrolled

December 1, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 5, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 8, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2019

Completed
Last Updated

December 11, 2018

Status Verified

December 1, 2018

Enrollment Period

6 months

First QC Date

November 30, 2018

Last Update Submit

December 8, 2018

Conditions

Outcome Measures

Primary Outcomes (4)

  • Tinnitus Handicap Inventory ( THI)

    Change from Baseline in Tinnitus Subjective Measures at 2 months, 4 months, 6 months: Tinnitus Handicap Inventory scale. Efficacy evaluation criteria: (1) cure: THI score was reduced to less than 16 points;(2) significant effect: THI score decreased by more than 17 points;(3) invalid: THI score value decreased \< 17 points or even increased.Efficiency is the sum of cure and effect.

    baseline, 2 months, 4 months, 6 months

  • Resting-state function magnetic resonance imaging(RS-fMRI) Regional homogeneity(ReHo) value

    Change from Baseline in Tinnitus Subjective Measures at 6 months: RS-fMRI ReHo value

    baseline, 6 months

  • Resting-state function magnetic resonance imaging(RS-fMRI) low-frequency wave amplitude (ALFF)

    Change from Baseline in Tinnitus Subjective Measures at 6 months: RS-fMRI ALFF

    baseline, 6 months

  • Visual Analogue Scale(VAS)

    Change from Baseline in Tinnitus Subjective Measures at 2 months, 4 months, 6 months: Visual Analogue Scale(VAS). The number 0 to 10 indicates the severity of symptoms, "0" means no symptoms, and "10" means the most severe

    baseline, 2 months, 4 months, 6 months

Study Arms (2)

CAABT

EXPERIMENTAL

CAABT(Cochleural Alternating Acoustic Beam Therapy) is an innovative tinnitus intervention which based on neural science and cochlear plastic research and aimed to reprogram the central auditory system to neutralize the discordant responses of the dysfunctioning cochlea via acoustic beaming stimuli.

Device: CAABT

TMT

ACTIVE COMPARATOR

TMT(tinnitus masking therapy) is a traditional tinnitus intervention. The masking sound is mainly white noise, and the intensity just covers tinnitus.

Device: TMT

Interventions

CAABTDEVICE

The sound generators with CAABT will be used 15 min each session, three times a day

CAABT
TMTDEVICE

The sound generators with TMT will be used 15 min each session, three times a day

TMT

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ages between 18-75 years
  • Tinnitus undergone for more than 6 months
  • Continuous attack, single tone dominated, annoying tinnitus
  • Able to cooperate with auditory function test and psychoacoustic test
  • The main tinnitus frequency is from 125Hz to 8000Hz
  • Willing to use the equipment daily during the test
  • Willing and able to follow up regularly
  • Ability to read and write Chinese, able to understand and complete questionnaires

You may not qualify if:

  • Secondary tinnitus
  • Pure tone audiometry shows conduction deafness or mixed deafness
  • Tinnitus main frequency threshold \>60dB
  • Receiving treatment for other tinnitus
  • MRI contraindications
  • Feeling uncomfortable with the treatment equipment or not being accepted

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Friendship Hospital,Capital Medical University

Beijing, Beijing Municipality, 100031, China

RECRUITING

Related Publications (2)

  • Tunkel DE, Bauer CA, Sun GH, Rosenfeld RM, Chandrasekhar SS, Cunningham ER Jr, Archer SM, Blakley BW, Carter JM, Granieri EC, Henry JA, Hollingsworth D, Khan FA, Mitchell S, Monfared A, Newman CW, Omole FS, Phillips CD, Robinson SK, Taw MB, Tyler RS, Waguespack R, Whamond EJ. Clinical practice guideline: tinnitus executive summary. Otolaryngol Head Neck Surg. 2014 Oct;151(4):533-41. doi: 10.1177/0194599814547475.

  • Liu C, Lv H, Jiang T, Xie J, He L, Wang G, Liu J, Wang Z, Gong S. The Cochleural Alternating Acoustic Beam Therapy (CAABT): A pre-clinical trial. Am J Otolaryngol. 2018 Jul-Aug;39(4):401-409. doi: 10.1016/j.amjoto.2018.04.002. Epub 2018 Apr 3.

MeSH Terms

Conditions

Tinnitus

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Shu-Sheng Gong, MD

    Beijing Friendship Hospital

    STUDY DIRECTOR

Central Study Contacts

Shu-Sheng Gong, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
director of Department of Otorhinolaryngology Head and Neck Surgery

Study Record Dates

First Submitted

November 30, 2018

First Posted

December 5, 2018

Study Start

December 1, 2018

Primary Completion

June 8, 2019

Study Completion

December 8, 2019

Last Updated

December 11, 2018

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will share

Data will be made available within 6 months of study completion

Shared Documents
STUDY PROTOCOL
Time Frame
Data access requests will be reviewed by an external Independent Review Panel.
Access Criteria
Data access requests will be reviewed by an external Independent Review Panel

Locations